Similar articles for PMID: 31262908

Year	Number of Results
2005	2
2006	1
2007	2
2008	4
2009	2
2010	6
2011	2
2012	5
2013	6
2014	19
2015	13
2016	24
2017	26
2018	17
2019	16
2020	16
2021	21
2022	16
2023	5
2024	0

1

2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.

Gerogianni I, Pitaraki E, Jagirdar RM, Kouliou O, Giannakou L, Giannopoulos S, Papazoglou E, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG. Gerogianni I, et al. Anticancer Res. 2019 Jul;39(7):3809-3814. doi: 10.21873/anticanres.13530. Anticancer Res. 2019. PMID: 31262908

2

In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes.

Papazoglou ED, Jagirdar RM, Kouliou OA, Pitaraki E, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG. Papazoglou ED, et al. Cancers (Basel). 2019 Sep 27;11(10):1446. doi: 10.3390/cancers11101446. Cancers (Basel). 2019. PMID: 31569615 Free PMC article.

3

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma.

Laszlo V, Valko Z, Ozsvar J, Kovacs I, Garay T, Hoda MA, Klikovits T, Stockhammer P, Aigner C, Gröger M, Klepetko W, Berger W, Grusch M, Tovari J, Waizenegger IC, Dome B, Hegedus B. Laszlo V, et al. J Mol Med (Berl). 2019 Feb;97(2):231-242. doi: 10.1007/s00109-018-1725-7. Epub 2018 Dec 11. J Mol Med (Berl). 2019. PMID: 30539198 Free PMC article.

4

Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.

Monica V, Lo Iacono M, Bracco E, Busso S, Di Blasio L, Primo L, Peracino B, Papotti M, Scagliotti G. Monica V, et al. Oncotarget. 2016 Nov 22;7(47):76577-76589. doi: 10.18632/oncotarget.10428. Oncotarget. 2016. PMID: 27391433 Free PMC article.

5

JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.

Zanellato I, Colangelo D, Osella D. Zanellato I, et al. Curr Cancer Drug Targets. 2018;18(8):816-828. doi: 10.2174/1568009617666170623101722. Curr Cancer Drug Targets. 2018. PMID: 28669341

6

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.

Cova E, Pandolfi L, Colombo M, Frangipane V, Inghilleri S, Morosini M, Mrakic-Sposta S, Moretti S, Monti M, Pignochino Y, Benvenuti S, Prosperi D, Stella G, Morbini P, Meloni F. Cova E, et al. Int J Nanomedicine. 2019 Jan 23;14:773-785. doi: 10.2147/IJN.S186344. eCollection 2019. Int J Nanomedicine. 2019. PMID: 30774332 Free PMC article.

7

EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.

Onen HI, Yilmaz A, Alp E, Celik A, Demiroz SM, Konac E, Kurul IC, Menevse ES. Onen HI, et al. Hum Exp Toxicol. 2015 Feb;34(2):117-26. doi: 10.1177/0960327114542965. Epub 2014 Jul 15. Hum Exp Toxicol. 2015. PMID: 25028262

8

Schedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma.

Karatkevich D, Deng H, Gao Y, Flint E, Peng RW, Schmid RA, Dorn P, Marti TM. Karatkevich D, et al. Int J Mol Sci. 2022 Oct 8;23(19):11949. doi: 10.3390/ijms231911949. Int J Mol Sci. 2022. PMID: 36233258 Free PMC article.

9

Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.

Hoda MA, Pirker C, Dong Y, Schelch K, Heffeter P, Kryeziu K, van Schoonhoven S, Klikovits T, Laszlo V, Rozsas A, Ozsvar J, Klepetko W, Döme B, Grusch M, Hegedüs B, Berger W. Hoda MA, et al. Mol Cancer Ther. 2016 Oct;15(10):2357-2369. doi: 10.1158/1535-7163.MCT-15-0846. Epub 2016 Aug 10. Mol Cancer Ther. 2016. PMID: 27512118

10

Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).

Tsao AS, Miao J, Wistuba II, Vogelzang NJ, Heymach JV, Fossella FV, Lu C, Velasco MR, Box-Noriega B, Hueftle JG, Gadgeel S, Redman MW, Gandara DR, Kelly K. Tsao AS, et al. J Clin Oncol. 2019 Oct 1;37(28):2537-2547. doi: 10.1200/JCO.19.00269. Epub 2019 Aug 6. J Clin Oncol. 2019. PMID: 31386610 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year